The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
about
Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL)EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicineAdoptive T-cell therapy for LeukemiaMolecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disordersStereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemia.Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia.An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractorinessAllogeneic hematopoietic cell transplant for prolymphocytic leukemia.CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma.Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia.How I treat CLL up front.CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.New additions to antibody panels in the characterisation of chronic lymphoproliferative disordersThe spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experience.Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry.Developing Molecular Signatures for Chronic Lymphocytic Leukemia.Membrane microdomain sphingolipids are required for anti-CD20-induced death of chronic lymphocytic leukemia B cells.Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutationsTargeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.Anti-CD antibody microarray for human leukocyte morphology examination allows analyzing rare cell populations and suggesting preliminary diagnosis in leukemia.Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cellsImmunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry.Characteristics of chronic lymphocytic leukemia in SenegalLoss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.Rapidly progressive renal failure due to chronic lymphocytic leukemia - Response to chlorambucilBcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications.Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathwayA complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia.Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.
P2860
Q21562355-DC60B584-F9F7-4EA1-9CCE-F1D60C1418EAQ24605023-B53BC41C-5552-4977-B8D0-F568AC65AF44Q27006934-1239400E-5367-4BA4-9CDA-C26AFFA90DB1Q28385156-E8247107-9F0F-48D5-9C95-1C9452C8E4A7Q30994095-B2CF60A3-0AE2-47E9-81AC-F7C6E68D4062Q33417346-8DA9CF77-AB4D-4958-9FC8-B009A0BB84B1Q33441622-F2A31222-3672-46B8-ADE5-2E6CCA19F35CQ33709543-C6E79F49-896C-4E61-B647-B7BA82E2B026Q33729489-8985A7B7-A044-465F-8580-FAA5B4025116Q33800449-E4008C7A-9B0C-4835-946C-B714D3D7F004Q33875380-06820741-BF20-48B3-A702-19209806E7E8Q33886052-13DA3B17-3F9A-4129-9D87-092D13C087B5Q34137158-08E1224D-BC2C-4CAD-ADB4-EA61C3140170Q34143223-6D67D48C-71A5-457D-BA21-875C93A4D2FFQ34459751-1BB582B5-D79A-491A-A82D-6EB463C72084Q34564844-EB5157DA-E435-4945-97D7-86FA9DEB551EQ35220198-7C57A37F-046D-4E71-BA2F-036ACE8551D2Q35586532-D31E91B0-A354-44E0-93E5-E924BEEAA1A3Q35653850-A08C165A-B052-4F30-B455-7E769128F702Q35717890-CB73D03E-D102-4573-A520-3AC5402E1740Q35749003-FEF0EFC5-BD02-4B3B-A712-596D94F48471Q35800840-DF9F7E87-8DAC-4FE5-9B7F-63E33E75BD38Q35891362-1C603D4C-1B10-419E-BE00-F46200687821Q35908496-CD6B7F29-E624-4785-AF19-6437583E61A3Q35932225-F9CCA9CB-A8C3-4399-8097-C770A44E8281Q35997917-2DE6FD26-D95B-4EB6-85C3-517262F9A393Q36160563-56BA6AF5-4FDD-46C1-A05F-AA352F7BDCEFQ36204525-AE989F4C-A849-43C2-8889-68A50E9B8759Q36283558-E6C793A4-214E-42CE-9341-764762F5C955Q36491873-71EF0E26-4CF5-450A-BBF8-A1AF17D6AAECQ36649130-085BD9AA-7DDF-4EB1-BF37-49497DBCF84BQ36651908-AFA4B5E5-2305-455B-AE67-8BD1CF6C7ED7Q36771955-15D3DED9-E290-42DE-AE3C-CE212CC4A21CQ36799192-740CA15A-B57B-4E44-B78D-E46A1ACFB987Q36824956-70BAF310-8B38-4C76-B331-694E94441029Q36862410-9C777A33-8392-4EE3-910E-3E9A2BA81547Q36871720-C45153B2-F5D1-4582-A6E1-1959CAE5FF5BQ36979738-B4715C92-435C-4952-873F-79A94BF5D8D7Q37112857-16C3160B-4B3A-4CB9-943E-5F14812347C7Q37195045-5BBF97A9-2AB9-4016-8235-C326C715C57A
P2860
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
The immunological profile of B ...... stem for the diagnosis of CLL.
@ast
The immunological profile of B ...... stem for the diagnosis of CLL.
@en
The immunological profile of B ...... stem for the diagnosis of CLL.
@nl
type
label
The immunological profile of B ...... stem for the diagnosis of CLL.
@ast
The immunological profile of B ...... stem for the diagnosis of CLL.
@en
The immunological profile of B ...... stem for the diagnosis of CLL.
@nl
prefLabel
The immunological profile of B ...... stem for the diagnosis of CLL.
@ast
The immunological profile of B ...... stem for the diagnosis of CLL.
@en
The immunological profile of B ...... stem for the diagnosis of CLL.
@nl
P2093
P1433
P1476
The immunological profile of B ...... stem for the diagnosis of CLL.
@en
P2093
Garcia Marco J
Houlihan A
Owusu-Ankomah K
P304
P577
1994-10-01T00:00:00Z